• Contact Us
Tuesday, March 2, 2021
Health Business
Advertisement
  • Home
  • News
    New TB research may lead to ‘perfect drug’

    Six counties record increase in TB cases, new report shows

    Why managing blood pressure matters during COVID-19 pandemic

    Africa’s universal health coverage agenda on course amid COVID-19 shocks

    Boehringer Ingelheim recognized for its contribution towards access to healthcare

    Boehringer Ingelheim recognized for its contribution towards access to healthcare

    Three ways virtual reality could transform mental health treatment

    Three ways virtual reality could transform mental health treatment

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
  • Home
  • News
    New TB research may lead to ‘perfect drug’

    Six counties record increase in TB cases, new report shows

    Why managing blood pressure matters during COVID-19 pandemic

    Africa’s universal health coverage agenda on course amid COVID-19 shocks

    Boehringer Ingelheim recognized for its contribution towards access to healthcare

    Boehringer Ingelheim recognized for its contribution towards access to healthcare

    Three ways virtual reality could transform mental health treatment

    Three ways virtual reality could transform mental health treatment

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
No Result
View All Result
Health Business
No Result
View All Result

WHO and partners launch vaccine injury compensation program for poorer countries

by Health Business
February 23, 2021
in News
0
Statement by WHO Director-General on World Health Day 2019
Share This:
The World Health Organization (WHO) and its partners have agreed to launch a program for claims of serious side effects among people in 92 poorer countries due to COVID-19 vaccination, the WHO said Monday in a statement.
“This is the first and only global vaccine injury compensation mechanism” operating on an international scale, the WHO statement said. According to WHO, the program, No-Fault Compensation, will offer eligible individuals “a fast, fair, robust and transparent process to receive compensation for rare but serious adverse events associated with COVAX-distributed vaccines until June 30 2022.”
COVAX is a facility led by WHO for better COVID-19 vaccine distribution. The statement said all vaccines procured or distributed through COVAX receive regulatory approval or an emergency use authorization to confirm their safety and efficacy. “But, as with all medicines, even vaccines that are approved for general use may, in rare cases, cause serious adverse reactions,” WHO said. “By providing a no-fault lump-sum compensation in full and final settlement of any claims, the COVAX program aims to significantly reduce the need for recourse to the law courts, a potentially lengthy and costly process,” said the statement.
By providing a mechanism to settle serious adverse events, the compensation program could help those who might have such effects, and help manufacturers to roll out vaccines to countries faster, said Seth Berkley, CEO of the Vaccine Alliance Gavi, in the statement.The program will be operated by ESIS, a subsidiary of the Zurich-based multinational insurance company Chubb Limited, the WHO said, adding that the compensation mechanism is to be funded by Gavi through a “levy charged on all doses of COVID-19 vaccines distributed through the COVAX Facility”.
WHO Director-General Tedros Adhanom Ghebreyesus praised the agreement, saying that this agreement offers further protection and confidence in the life-saving power of vaccines.As the world is struggling to contain the pandemic, vaccination is underway in some countries with the already-authorized coronavirus vaccines.
Meanwhile, 251 candidate vaccines are still being developed worldwide — 70 of them in clinical trials — in countries including Germany, China, Russia, Britain and the United States, according to information released by WHO on Feb. 19.
Share This:
Previous Post

China to aid 19 more African nations with COVID-19 vaccines

Next Post

What WHO COVID-19 experts say about their month-long Wuhan visit

Related Posts

New TB research may lead to ‘perfect drug’
News

Six counties record increase in TB cases, new report shows

March 2, 2021
Why managing blood pressure matters during COVID-19 pandemic
News

Africa’s universal health coverage agenda on course amid COVID-19 shocks

March 1, 2021
Boehringer Ingelheim recognized for its contribution towards access to healthcare
News

Boehringer Ingelheim recognized for its contribution towards access to healthcare

March 1, 2021
Next Post
What WHO COVID-19 experts say about their month-long Wuhan visit

What WHO COVID-19 experts say about their month-long Wuhan visit

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Follow Us

Most Read

  • Statement by WHO Director-General on World Health Day 2019

    WHO and partners launch vaccine injury compensation program for poorer countries

    0 shares
    Share 0 Tweet 0
  • Nakuru county starts construction of Sh157m Njoro Sub-County Referral Hospital

    0 shares
    Share 0 Tweet 0
  • Unitaid, partners launch COVID-19 oxygen emergency taskforce to help low-income countries

    0 shares
    Share 0 Tweet 0
Health Business

Health Business contains need-to-know features, news and case studies that explain the administrative and commercial issues affecting healthcare and hospital management. Health Business supports several high profile exhibitions - coverage of which is always timed for maximum impact. Regular topics include ICT, Finance/Funding, Facilities Management, Security, Health & Safety. Contributors range from government ministers through to top-level health administrators and association chairs.

Top Stories

New TB research may lead to ‘perfect drug’

Six counties record increase in TB cases, new report shows

March 2, 2021
Why managing blood pressure matters during COVID-19 pandemic

Africa’s universal health coverage agenda on course amid COVID-19 shocks

March 1, 2021
Boehringer Ingelheim recognized for its contribution towards access to healthcare

Boehringer Ingelheim recognized for its contribution towards access to healthcare

March 1, 2021

Interests

  • Events
  • Finance
  • Government
  • Magazines
  • Medical Research
  • News
  • Politics & Policy
  • Providers
  • Public Health
  • Regulation, Enforcement & Compliance
  • Technology
  • Videos

Follow Us

  • Contact Us

© 2019 | Site by Mark & Ryse.

No Result
View All Result
  • Home
  • News
  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos

© 2019 | Site by Mark & Ryse.